White House To Disband COVID-19 Team In May

The Biden administration is set to disband the White House COVID-19 response team in May after the public health emergency ends.

The team was created by the Trump administration in February 2020 and played a prominent role in Trump’s final and Biden’s first years as president, particularly under Dr. Anthony Fauci’s leadership. However, as the pandemic fades from the headlines, the team is set to be disbanded in a couple of months, multiple officials told the Washington Post.

A White House official praised the work of the team in a statement to the outlet, arguing that its success meant the United States could now transition out of emergency status.

“As a result of this administration’s historic response to COVID-19, we as a nation are in a safer, better place than we were three years ago,” the official said. “COVID no longer disrupts our lives because of investments and our efforts to mitigate its worst impacts. COVID is not over, fighting it remains an administration priority, and transitioning out of the emergency phase is the natural evolution of the COVID response.”

The team was expanded to three dozen staffers under the Biden administration and was taken over by national coordinator Ashish Jha following Fauci’s departure at the end of December. Jha is expected to continue serving as its head until its disbandment.

Public attention toward the pandemic has shifted away from immediate prevention and toward figuring out the origin of the virus, which Republicans and some intelligence agencies largely believe came from a Chinese lab.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square